lenvatinib-mesilaatti - leitarniðurstöður

eisai new zealand limited - lenvatinib mesilate 12.25mg equivalent to lenvatinib 10mg - capsule - 10 mg - active: lenvatinib mesilate 12.25mg equivalent to lenvatinib 10mg excipient: calcium carbonate hyprolose as 25mg low-substituted hydroxypropyl cellulose + 3mg hydroxypropylcellulose hypromellose iron oxide black iron oxide red iron oxide yellow mannitol microcrystalline cellulose potassium hydroxide propylene glycol purified talc shellac titanium dioxide - lenvima is indicated for the treatment of patients with progressive, locally advanced or metastatic, radioactive iodine refractory differentiated thyroid cancer.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

lenvima

eisai new zealand limited - lenvatinib mesilate 4.9mg equivalent to lenvatinib 4mg - capsule - 4 mg - active: lenvatinib mesilate 4.9mg equivalent to lenvatinib 4mg excipient: calcium carbonate hyprolose as 25mg low-substituted hydroxypropyl cellulose + 3mg hydroxypropylcellulose hypromellose iron oxide black iron oxide red iron oxide yellow mannitol microcrystalline cellulose potassium hydroxide propylene glycol purified talc shellac titanium dioxide - lenvima is indicated for the treatment of patients with progressive, locally advanced or metastatic, radioactive iodine refractory differentiated thyroid cancer.

Panama - enska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

lenvima 4 mg caspulas duras

gbt- grupo biotoscana, s.a. - lenvatinib (mesilato) - lenvatinib (mesilato)....4,00 mg

Panama - enska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

lenvima 10 mg capsulas duras

gbt- grupo biotoscana, s.a. - lenvatinib (mesilato) - lenvatinib (mesilato)....10,00 mg